tiprankstipranks
Renovaro Biosciences (RENB)
NASDAQ:RENB

Renovaro Biosciences (RENB) Technical Analysis

114 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
3Neutral
13Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Renovaro Biosciences’s (RENB) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Renovaro Biosciences is a Buy.
Renovaro Biosciences’s (RENB) 20-Day exponential moving average is 1.51, while Renovaro Biosciences’s (RENB) share price is $1.4, making it a Sell.
Renovaro Biosciences’s (RENB) 50-Day exponential moving average is 1.60, while Renovaro Biosciences’s (RENB) share price is $1.4, making it a Sell.

Renovaro Biosciences (RENB) Pivot Points

Jul 18, 2024, 05:37 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.29
1.35
1.40
1.46
1.51
1.57
1.62
Fibonacci
1.35
1.39
1.42
1.46
1.50
1.53
1.57
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Renovaro Biosciences (RENB) Moving Averages

Jul 18, 2024, 05:37 AM
Period
Simple
Exponential
MA5
1.47Sell
1.46Sell
MA10
1.52Sell
1.50Sell
MA20
1.54Sell
1.51Sell
MA50
1.40Buy
1.60Sell
MA100
1.96Sell
1.93Sell
MA200
2.78Sell
2.34Sell
Renovaro Biosciences’s (RENB) 10-Day exponential moving average is 1.50, while Renovaro Biosciences’s (RENB) share price is $1.4, making it a Sell.
Renovaro Biosciences’s (RENB) 100-Day exponential moving average is 1.93, while Renovaro Biosciences’s (RENB) share price is $1.4, making it a Sell.
Renovaro Biosciences’s (RENB) stock price is $1.4 and Renovaro Biosciences’s (RENB) 50-day simple moving average is 1.40, creating a Buy signal.
Renovaro Biosciences’s (RENB) stock price is $1.4 and Renovaro Biosciences’s (RENB) 100-day simple moving average is 1.96, creating a Sell signal.
Renovaro Biosciences’s (RENB) stock price is $1.4 and Renovaro Biosciences’s (RENB) 200-day simple moving average is 2.78, creating a Sell signal.

Renovaro Biosciences (RENB) Technical Indicators

Jul 18, 2024, 05:37 AM
Name
Value
Implied Action
RSI (14)
43.18
Neutral
STOCH (9,6)
8.92
Buy
STOCHRSI (14)
18.23
Buy
MACD (12,26)
>-0.01
Buy
ADX (14)
33.13
Neutral
Williams %R
-93.98
Buy
CCI (14)
-151.68
Buy
ATR (14)
0.19
-
Ultimate Oscillator
40.26
Neutral
ROC
-11.95
Sell
Renovaro Biosciences’s (RENB) Relative Strength Index (RSI) is 43.18, creating a Neutral signal.
Renovaro Biosciences’s (RENB) Trend Strength Indicator (ADX) is 33.13, creating a Neutral signal.
Renovaro Biosciences’s (RENB) Commodity Channel Index (CCI) is -151.68, creating a Buy signal.
Renovaro Biosciences’s (RENB) Price Rate of Change (ROC) is -11.95, creating a Sell signal.

FAQ

Is RENB a Buy, Hold, or Sell?
Based on RENB’s technical indicators, RENB is a Sell.
    What is RENB’s RSI (14)?
    RENB’s RSI (14) is 43.18, which suggests RENB is a Neutral.
      What is RENB’s MACD?
      RENB’s MACD is >-0.01, which suggests RENB is a Buy.
        What is RENB’s 5-day moving average?
        RENB’s 5-day moving average is 1.47, which suggests RENB is a Sell.
          What is RENB’s 20-day moving average?
          RENB 20-day moving average is 1.54, which suggests RENB is a Sell.
            What is RENB’s 50-day moving average?
            RENB’s 50-day moving average is 1.40, which suggests RENB is a Buy.
              What is RENB’s 200-day moving average?
              RENB’s 200-day moving average is 2.78, which suggests RENB is a Sell.
                What is RENB’s Williams % R (14)?
                RENB’s Williams % R (14) is -93.98, which suggests RENB is a Buy.
                  What is RENB’s CCI (14)?
                  RENB’s CCI (14) is -151.68, which suggests RENB is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis